I do think based on current figures, value is starting to appear in GSS. I expect the need for Covid testing will continue for a couple of years yet, especially as the world opens up to global travel.
The main questions I have are whether GSS is growing, losing or maintaining its market share of covid tests in Australia? Are expansion strategies into overseas countries bearing fruit? And are we seeing growth in the non-covid tests? I guess the answer to these questions we'll find out very shortly in the quarterly. I do agree though that management need to communicate with shareholders more often.
Global expansion post Covid 19, page-14
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
77.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $174.4M | |||
| Open | High | Low | Value | Volume |
| 77.0¢ | 77.0¢ | 76.0¢ | $73.36K | 95.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 74.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 77.0¢ | 89 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| GSS (ASX) Chart |